Common Contracts
3 similar Severance Buy-Out Agreement, Compromise and Release contracts by Stemcells Inc
Dear Ian Massey: As you know, StemCells, Inc. (the “Company” or “StemCells”) has terminated its Phase II Pathway Study and has begun a wind down of the Company’s operations. The Company has determined that both your continued employment and...Severance Buy-Out Agreement, Compromise and Release • August 15th, 2016 • Stemcells Inc • Biological products, (no disgnostic substances) • California
This letter supersedes any and all separation, severance and salary continuation arrangements, programs and plans which were previously offered by StemCells, Inc., and in particular supersedes and terminates section 7 of your Employment Agreement, dated March 6, 2015 (collectively, the “Superseded Agreement”). In other words, by your counter-signature below, you agree that you will not receive, and release all entitlement to, any payments and other benefits provided for under the Superseded Agreement, except as otherwise provided herein.
Dear Greg: As you know, StemCells, Inc. (the “Company” or “StemCells”) has terminated its Phase II Pathway Study and has begun a wind down of the Company’s operations. The Company has determined that both your continued employment and cooperation to...Severance Buy-Out Agreement, Compromise and Release • August 15th, 2016 • Stemcells Inc • Biological products, (no disgnostic substances) • California
This letter supersedes any and all separation, severance and salary continuation arrangements, programs and plans which were previously offered by StemCells, Inc., and in particular supersedes and terminates section 8 of your Employment Agreement, dated November 13, 2013 (collectively, the “Superseded Agreement”). In other words, by your counter-signature below, you agree that you will not receive, and release all entitlement to, any payments and other benefits provided for under the Superseded Agreement, except as otherwise provided herein.
Dear Ken: As you know, StemCells, Inc. (the “Company” or “StemCells”) has terminated its Phase II Pathway Study and has begun a wind down of the Company’s operations. The Company has determined that both your continued employment and cooperation to...Severance Buy-Out Agreement, Compromise and Release • August 15th, 2016 • Stemcells Inc • Biological products, (no disgnostic substances) • California
This letter supersedes any and all separation, severance and salary continuation arrangements, programs and plans which were previously offered by StemCells, Inc., and in particular supersedes and terminates your Employment Agreement, dated February 2, 2007 as amended on August 6, 2009 and March 15, 2016 (collectively, the “Superseded Agreement”). In other words, by your counter-signature below, you agree that you will not receive, and release all entitlement to, any payments and other benefits provided for under the Superseded Agreement, except as otherwise provided herein.
